Welcome to PsychU!

Future Of Psychopharmacology: Is New Treatment Innovation Still Alive?

While past decades saw a boom in the development of innovative new treatments in the field of psychiatry, the pace has slowed in more recent years. In this webinar, Stephen Stahl, MD, PhD discusses the reasons behind the slowing of psychopharmacologic advances in recent years, addresses the importance of targeting symptoms theorized to be caused by inefficiently functioning neurocircuits common to a large array of psychiatric disorders, and examines the future potential for genetic and imaging biomarkers to aid in …

Join PsychU today at no cost for access to this and other premium content!

Join today for instant access to all PsychU content, events, and more!

Membership is free!

Specialty (select all that apply)*
Zip / Postal Code*

Choose Your Unique Login

Your username can only contain lowercase letters (a-z) and numbers.
Your password must be at least 8 characters Hint: Must use combination of lower case letters, upper case letters, numbers and special characters like !@#$.

I agree to the following terms

I agree to the following terms:*
I agree to the following terms*
Direct Care Provider
Clinician Newsletter
Management Newsletter
This field is for validation purposes and should be left unchanged.